ImmuCell Corporation (ICCC)
Largest Insider Buys in Sector
ICCC Stock Price History Chart
ICCC Stock Performance
About ImmuCell Corporation
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, …
Insider Activity of ImmuCell Corporation
Over the last 12 months, insiders at ImmuCell Corporation have bought $0 and sold $0 worth of ImmuCell Corporation stock.
On average, over the past 5 years, insiders at ImmuCell Corporation have bought $30,618 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $8,000 was made by Cunningham David () on 2022‑06‑13.
List of Insider Buy and Sell Transactions, ImmuCell Corporation
| 2022-06-13 | 1,000 0.0134% | $8.00 | $8,000 | -5.19% | ||||
| 2020-03-12 | director | 2,000 0.0259% | $4.00 | $8,000 | +40.70% | |||
| 2020-03-11 | director | 4,600 0.0591% | $4.28 | $19,688 | +30.00% | |||
| 2020-02-27 | director | 5,130 0.0677% | $4.98 | $25,547 | +12.94% | |||
| 2018-08-16 | director | 3,000 0.0387% | $6.67 | $20,010 | +4.04% | |||
| 2017-07-27 | 170,000 1.7068% | $5.25 | $892,500 | +6.81% | ||||
| 2017-07-27 | 30,000 0.3012% | $5.25 | $157,500 | +6.81% | ||||
| 2017-03-14 | director | 1,197 0.0155% | $5.44 | $6,510 | +29.89% | |||
| 2017-03-13 | director | 803 0.0103% | $5.42 | $4,352 | +28.81% | |||
| 2016-11-07 | director | 4,000 0.0529% | $5.19 | $20,760 | +19.82% | |||
| 2016-08-22 | director | 3,000 0.0384% | $7.14 | $21,431 | -15.97% | |||
| 2016-07-08 | Sale | VP & Chief Scientific Officer | 1,935 0.0242% | $6.55 | $12,669 | -10.22% | ||
| 2016-07-07 | Sale | VP & Chief Scientific Officer | 265 0.0035% | $6.54 | $1,732 | -6.11% | ||
| 2016-07-06 | Sale | VP & Chief Scientific Officer | 2,426 0.0313% | $6.59 | $15,979 | -7.81% | ||
| 2016-07-05 | Sale | Vice President and CSO | 2,600 0.0331% | $6.58 | $17,106 | -8.78% | ||
| 2016-07-01 | Sale | Vice President and CSO | 2,774 0.0373% | $6.88 | $19,095 | -8.18% | ||
| 2016-03-21 | director | 955 0.0126% | $6.67 | $6,370 | +1.61% | |||
| 2016-01-29 | 9,522 0.1099% | $5.25 | $49,991 | +13.46% | ||||
| 2016-01-29 | director | 6,666 0.077% | $5.25 | $34,997 | +13.46% | |||
| 2016-01-29 | director | 1,904 0.022% | $5.25 | $9,996 | +13.46% |
Insider Historical Profitability
| ROTHSCHILD JONATHAN E | 510158 5.7247% | $4.71 | 107 | 0 | +21.25% | |
| PESSIN NORMAN H | 170000 1.9076% | $4.71 | 1 | 0 | +6.81% | |
| BRIGHAM MICHAEL F | President & CEO | 154870 1.7378% | $4.71 | 5 | 0 | |
| CRABB JOSEPH H | VP & Chief Scientific Officer | 105111 1.1795% | $4.71 | 5 | 5 | |
| Tomsche David Scott | director | 85519 0.9596% | $4.71 | 28 | 0 | +13.65% |
Institutional Investor Ownership
| The Vanguard Group | $1.15M | 2.77 | 216,327 | +4.71% | +$51,521.29 | <0.0001 | |
| Renaissance Technologies | $662,000.00 | 1.6 | 124,889 | -1.03% | -$6,890.92 | <0.01 | |
| Cresset Asset Management Llc | $549,112.00 | 1.33 | 103,606 | 0% | +$0 | <0.01 | |
| Bleichroeder Lp | $538,448.00 | 1.3 | 101,594 | 0% | +$0 | 0.14 | |
| Morgan Stanley | $342,995.00 | 0.83 | 64,716 | -23.48% | -$105,247.46 | <0.0001 |